ERBB2 and neoplasm: The finding that our ACE-induced CTL specifically lysed HER-2/neu+ HLA-A2.1+ tumour cells demonstrates their ability to recognise naturally processed peptides expressed and presented on the tumour cell surface in the context of HLA-A2.1 molecules.